Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

ICER to review the role of health insurers in determining patient access to prescription drugs

ICER to review the role of health insurers in determining patient access to prescription drugs

Non-profit research institute will evaluate how health insurance policies may harm patient access to treatment. ... yesterday. The first annual assessment into how health insurance policies may harm patient access to treatment will seek input from

Latest news

More from news
Approximately 1 fully matching, plus 223 partially matching documents found.

Latest Intelligence

  • EU cross-border healthcare EU cross-border healthcare

    Patients whose very survival depends on therapies that can only be delivered abroad must face a flurry of challenges to access the treatment that will hopefully change their lives forever. ... Furthermore, both pathways are impacted by several challenges

  • Could the rare disease community teach pharma a lesson? Could the rare disease community teach pharma a lesson?

    by Leigh Ansell. Patient support programmes (PSPs) provide help, information and advice to patients, from diagnosis through treatment. ... They get involved with patient organisations, from fundraising and events to advocacy for research funding and

  • Rare genetic diseases – what’s in store for 2021? Rare genetic diseases – what’s in store for 2021?

    The cross-collaboration has also brought forward fundamental changes and breakthroughs for the treatment of many rare genetic diseases. ... We’re looking at digital advances that would improve access to treatment and the overall patient experience.

  • New truths and realities in these strange times New truths and realities in these strange times

    The issue may be as simple as not being able to access their physician/GP in the usual manner, not having the usual access to their medications as regularly (if at ... Patients are also worried about access to care or treatment; the difficulties of

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    It will take multiple evolutions before we get an AD treatment equivalent to today’s smartphones. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.

More from intelligence
Approximately 1 fully matching, plus 54 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 28 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...